Victory Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$574K Sell
42,381
-443,128
-91% -$5.3M ﹤0.01% 2044
2026
Q1
$2.91M Sell
485,509
-28,522
-6% -$215K ﹤0.01% 1501
2025
Q4
$3.69M Buy
514,031
+54,525
+12% +$431K ﹤0.01% 1412
2025
Q3
$4.91M Buy
459,506
+14,848
+3% +$146K ﹤0.01% 1350
2025
Q2
$4.3M Buy
444,658
+42,691
+11% +$440K ﹤0.01% 1363
2025
Q1
$5.99M Buy
401,967
+180,689
+82% +$2.78M 0.01% 1226
2024
Q4
$3.3M Buy
221,278
+37,980
+21% +$619K ﹤0.01% 1366
2024
Q3
$3.51M Buy
183,298
+102,663
+127% +$2.13M ﹤0.01% 1348
2024
Q2
$1.67M Sell
80,635
-2,055
-2% -$40.8K ﹤0.01% 1493
2024
Q1
$1.55M Sell
82,690
-28,920
-26% -$496K ﹤0.01% 1533
2023
Q4
$1.61M Sell
111,610
-955,450
-90% -$13M ﹤0.01% 1501
2023
Q3
$18.5M Buy
1,067,060
+161,582
+18% +$3.37M 0.02% 785
2023
Q2
$18.8M Buy
905,478
+27,375
+3% +$595K 0.02% 795
2023
Q1
$20.7M Buy
878,103
+44,173
+5% +$1.19M 0.02% 770
2022
Q4
$23.3M Buy
833,930
+194,002
+30% +$4.96M 0.03% 719
2022
Q3
$15M Buy
639,928
+66,166
+12% +$2M 0.02% 921
2022
Q2
$19.4M Buy
573,762
+66,402
+13% +$2.33M 0.02% 841
2022
Q1
$17.7M Sell
507,360
-2,407
-0.5% -$82.3K 0.02% 932
2021
Q4
$15.5M Buy
509,767
+71,555
+16% +$2.33M 0.01% 1003
2021
Q3
$14.4M Buy
438,212
+373,047
+572% +$11.9M 0.01% 991
2021
Q2
$1.97M Buy
+65,165
New +$2.15M ﹤0.01% 1637

Other funds holding OGN

Victory Capital Management's OGN Position: Q2 2026 in Review

Victory Capital Management reduced its Organon & Co (OGN) stake by 91% in Q2 2026, selling an estimated $5.3M and leaving 42,381 shares worth $574K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Victory Capital Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $23.3M in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Victory Capital Management held 42,381 shares of Organon & Co worth $574K as of Q2 2026.
  • Victory Capital Management sold 443,128 Organon & Co shares in Q2 2026, an estimated $5.3M.
  • Organon & Co made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2044 holding.
  • Victory Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Victory Capital Management's Organon & Co position peaked at $23.3M in Q4 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.